NKT cell-targeted vaccination plus anti-4-1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma. [electronic resource]
Publication details: Oncoimmunology Mar 2015Description: e990793 p. digitalISSN:- 2162-4011
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.